Antimicrobial Use in Veterinary Medicine Today and Tomorrow - Dr. Ron DeHaven , AVMA Executive Vice-President, from the 2012 NIAA One Health Approach to Antimicrobial Resistance and Use Symposium, October 26-27, 2012, Columbus, OH, USA.
More presentations at:
http://www.trufflemedia.com/agmedia/conference/2012-one-health-to-approach-antimicrobial-resistance-and-use
Dr. Ron DeHaven - Antimicrobial Use in Veterinary Medicine Today and Tomorrow
1. Antimicrobial
Use in Veterinary Medicine
Today and Tomorrow...
®
W. Ron DeHaven, DVM, MBA
Executive Vice President and CEO
American Veterinary Medical Association
3. Uses of Antibiotics
®
Animal uses currently approved by FDA
Treatment
Control
Prevention
Production Uses
(Growth Promotion/Feed Efficiency)
4. Sources and Regulatory Oversight
of Antimicrobials
®
Over-the-Counter (OTC)
Producers, only as approved on label; can be feed or water
Added to feed by a feed mill or producer as directed on the
FDA approved label
Veterinary Feed Directive (VFD)
Currently only 2 drugs are approved - florfenicol (Nuflor) and
tilmicosin (Pulmotil)
OTC => VFD medically important antimicrobials in feed
Prescription (Rx) –
GFI 213 transitions medically important antimicrobials in
water from OTC to Rx and allows mechanism to seek
therapeutic claims for production use antimicrobials
5. Differences in Use
®
Human Medicine
For treatment or prevention
Physician determines indication and route of administration,
dose, frequency, and duration of treatment
No restrictions on extra-label or "off label" uses
Food Animals
Drug only approved for specific indications, e.g., respiratory
disease due to Pasteurella multocida
Only allowed at specific dosage, duration, frequency, and
route of administration
Extra label uses heavily regulated
6. A Source of Controversy…
®
Antimicrobial use in food producing animals can serve as a
reservoir for antimicrobial resistance, i.e., the more we
expose the organisms to antimicrobials the more we give
them the opportunity to develop resistance.
Although that may be true in a very simplified, general sense,
there is no clear scientific evidence of how, and to what
extent such exposure affects human health.
7. Additional Complexity
®
While plausible, there is no hard evidence that cases of
human infection with a resistant bacteria have been
caused by use of antimicrobials in food animals.
There is little to no evidence that restricting or eliminating
the use of antimicrobials in food-producing animals
would improve human health or reduce the risk of
antimicrobial resistance to humans.
9. Impact of Animal Health on
Foodborne Risk
®
Healthy: Passed FSIS antemortem inspection
(not visibly ill)
Some (~7%) had internal adhesions from previous
chronic infection
Carcasses 90% more likely to be contaminated
with Salmonella
Photo credit: Hudson ISD FFA
10. Which is Preferred?
®
Less Use vs. More Use
Lower dose in more animals (today)
Higher dose in fewer animals (tomorrow?)
Stronger drugs?
Or more culls?
11. Differing Approaches
®
Discontinue Use
Although we may not know the degree of risk, why
should we take any chances?
Let’s eliminate or reduce the use of antibiotics in animals
on the possibility that this is jeopardizing human health.
Continue Use
Let’s not take any action that is not based on a scientific
risk assessment.
The benefits to animal health, welfare, and food safety
outweigh the risks to human health based on risk
assessments done to date.
Novel Approach ?
13. AVMA's Current Approach
®
Judicious use of antimicrobials
Maximize benefit, minimize risks
Supports veterinary involvement in any use of
antimicrobials
Actions to limit use should be based on:
Available scientific research
Risk-based assessments
14. Preservation of Antibiotics for Medical
Treatment Act (PAMTA)
®
Purpose
Preserve the effectiveness of medically important
antibiotics used in the treatment of human and animal
diseases by reviewing the safety of certain antibiotics for
nontherapeutic purposes in food-producing animals.
Nontherapeutic Use
Use of the drug as a feed or water additive for an animal
in the absence of any clinical sign of disease in the
animal for growth promotion, feed efficiency, weight gain,
routine disease prevention, or other routine purpose.
15. AVMA’s Position on PAMTA
®
Not supported by science (based on
AVMA’s interpretation)
Lacks risk-based assessments
Has potential to eliminate 2 or 3 of the 4
approved uses of antibiotics in animals
Animal welfare implications
16. Greater Veterinary Oversight
®
Some believe this is the way to go – supported
by market research
General agreement within AVMA (We think!)
Workforce shortage issue (some disagree)
VFD is primary vehicle for greater oversight in
antimicrobials in feed
Degree of oversight proportionate to risk
AVMA would do all we can to make it work!
Veterinary Oversight Steering Committee
17. Legislation versus Regulation
®
Legislation
Less opportunity for scientific input & evaluation
Can be more politically motivated
Regulation (rulemaking process)
Provides months/years for input
More of a deliberative process
Statutory authority already exists
18. FDA-CVM Perspective
®
Innovative use of VFD
Supportive of and recognition of the importance of
treatment, control, and prevention
Phase in greater veterinary oversight
Phase out growth promotion/feed efficiency
Data needed – Is Growth Promotion really
prevention?
21. So, where are we headed?
®
More Veterinary Oversight
Workforce concerns
More responsibility and more credit - yet also
more blame
Role of Veterinarians? Huge!